November 15, 2022

Dermagnostix announces commercial pilot of PsorX-LabDisk

Dermagnostix announces the commercial pilot of PsorX LabDisks as CE-IVD test kits in Germany. PsorX is a first in-class molecular test for differential diagnosis of psoriasis and eczema or atopic dermatitis. PsorX two-gene classifier accurately and efficiently distinguishes psoriasis from all forms of eczema, even in cases where conventional diagnostic methods have failed.


“Providing our first customer with PsorX as CE-IVD marked test kit signifies a major milestone in making our diagnostic solutions available to patients globally,”  Natalie Garzorz-Stark, CEO Dermagnostix.

“We are looking forward to soon entering the next phase of commercialization in Europe. Now the innovative PsorX test will allow our customers to improve outcomes for inflammatory disease patients at the point of need.”